v3.25.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenue:      
Revenues $ 297,176 $ 266,274 $ 202,085
Cost of goods sold $ 100,069 $ 83,970 $ 64,514
Cost, Product and Service [Extensible Enumeration] Product revenue, net Product revenue, net Product revenue, net
Gross profit $ 197,107 $ 182,304 $ 137,571
Operating expenses:      
Selling, general and administrative 220,786 198,025 164,944
Research and development 9,576 9,172 6,556
In-process research and development 0 0 8,869
Revaluation of contingent royalty obligation payable to Evolus Founders (6,381) 7,176 4,257
Depreciation and amortization 4,345 2,342 2,178
Restructuring costs 1,443 0 0
Total operating expenses 229,769 216,715 186,804
Loss from operations (32,662) (34,411) (49,233)
Other income (expense):      
Interest income 1,931 3,263 860
Interest expense (19,694) (18,735) (13,832)
Other income (expense), net (539) 127 696
Loss before income taxes (50,964) (49,756) (61,509)
Income tax expense (677) (664) (176)
Net loss (51,641) (50,420) (61,685)
Other comprehensive income (loss), net of tax:      
Currency translation adjustment 749 (478) (90)
Comprehensive loss $ (50,892) $ (50,898) $ (61,775)
Net loss per share, basic (in dollars per share) $ (0.80) $ (0.81) $ (1.08)
Net loss per share, diluted (in dollars per share) $ (0.80) $ (0.81) $ (1.08)
Weighted-average shares outstanding used to compute basic net loss per share (in shares) 64,468,913 62,016,853 56,918,721
Weighted-average shares outstanding used to compute diluted net loss per share (in shares) 64,468,913 62,016,853 56,918,721
Product revenue, net      
Revenue:      
Revenues $ 294,956 $ 264,306 $ 199,721
Service revenue      
Revenue:      
Revenues $ 2,220 $ 1,968 $ 2,364